MH3D Wins Commercial Innovation Award of the Year at WMIC 2025

Ann Arbor, MI – October 6, 2025 – MH3D Inc. is proud to announce that it has been awarded the Commercial Innovation Award of the Year at the World Molecular Imaging Congress (WMIC) 2025.

This award recognizes MH3D’s groundbreaking work in advancing high-resolution, CZT-based SPECT imaging solutions designed to accelerate theranostics and radioligand therapy research. The honor underscores the impact of MH3D’s technology on the global molecular imaging community, providing researchers with sharper quantification, higher sensitivity, and multi-isotope capabilities for next-generation nuclear medicine.

MH3D extends its sincere gratitude to the partners and collaborators who made this milestone possible, including Scintica Instrumentation, Geofabrica, the UK’s Science and Technology Facilities Council (STFC), Aspect System GmbH. Each has played a vital role in supporting MH3D’s mission to bring cutting-edge imaging technology to the preclinical and clinical research communities.

Looking ahead, MH3D will continue to push the boundaries of imaging science and collaborate with global leaders to enable the future of personalized medicine through precise and efficient imaging platforms.